Regulation of protrusion shape and adhesion to the substratum during chemotactic responses of mammalian carcinoma cells.
We report here the first direct observation of chemotaxis to EGF by rat mammary carcinoma cells. When exposed to a gradient of EGF diffusing from a micropipette, MTLn3 cells displayed typical ameboid chemotaxis, extending a lamellipod-like protrusion and moving toward the pipette. Using a homogeneous upshift in EGF to model stimulated lamellipod extension (J. E. Segall et al., 1996, Clin. Exp. Metastasis 14, 61-72), we analyzed the relationship between adhesion and chemoattractant-stimulated protrusion. Exposure to EGF led to a rapid remodeling of the adhesive contacts on adherent cells, in synchrony with extension of a flat lamellipod over the substratum. EGF-stimulated lamellipods still extended in the presence of adhesion-blocking peptides or over nonadhesive surfaces. They were, however, slightly shorter and retracted rapidly under those conditions. The major protrusive structure observed on well-spread, adherent cells, after EGF stimulation was a flat broad lamellipod, whether or not in contact with the substratum, while cells in suspension showed transient protrusive activity over the entire cell surface. We conclude that the initial adhesive status of the cell conditions the shape of the outcoming protrusion. Altogether our results suggest that, although adhesive contacts are not necessary for lamellipod extension, they play a role in stabilizing the protrusion as well as in the control of its final shape and amplitude.
Bailly
M
M
Department of Anatomy and Structural Biology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, 10461, USA. bailly@aecom.yu.edu
Yan
L
L
Whitesides
G M
GM
Condeelis
J S
JS
Segall
J E
JE
D000818:Animals; D002277:Carcinoma / Q000473:pathology*; D002448:Cell Adhesion / Q000187:drug effects; D048429:Cell Size / Q000187:drug effects; D002630:Chemotactic Factors / Q000494:pharmacology* / Q000502:physiology*; D002633:Chemotaxis / Q000187:drug effects*; D004815:Epidermal Growth Factor / Q000494:pharmacology* / Q000502:physiology*; D015674:Mammary Neoplasms, Animal / Q000473:pathology*; D009362:Neoplasm Metastasis; D051381:Rats; D014407:Tumor Cells, Cultured
D002630:Chemotactic Factors; D004815:Epidermal Growth Factor